Nova Patents
AT501766T

Ophthalmic drug delivery system

Abstract

This record has no abstract on file.

Term

Term ended

Expired 20 May 2024, 2.3 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

23 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims3

Priority claims
DocumentOfficeKindDate
47188303United States of AmericaP
48530503United States of AmericaP
2004016181United States of AmericaW

Members23

Family members, oldest first
DocumentOfficeKind
CA2526362A1CanadaA1
WO2004103478A1World Intellectual Property Organization (WIPO)A1
US2004256487A1United States of AmericaA1
EP1624938A1European Patent Office (EPO)A1
HK1086776AHong Kong, ChinaA
US2007119968A1United States of AmericaA1
US2007119969A1United States of AmericaA1
WO2008094481A2World Intellectual Property Organization (WIPO)A2
WO2008094481A3World Intellectual Property Organization (WIPO)A3
EP1624938A4European Patent Office (EPO)A4
US2009114742A1United States of AmericaA1
US2009149829A1United States of AmericaA1
WO2010078428A1World Intellectual Property Organization (WIPO)A1
US2010222752A1United States of AmericaA1
US7883031B2United States of AmericaB2
EP1624938B1European Patent Office (EPO)B1
AT501766TThis recordAustriaT
ATE501766T1AustriaT1
DE602004031829D1GermanyD1
US8012136B2United States of AmericaB2
CA2526362CCanadaC
US8545463B2United States of AmericaB2
US8936021B2United States of AmericaB2